ZYME vs NTLA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

ZYME

30.0
AI Score
VS
NTLA Wins

NTLA

32.9
AI Score

Investment Advisor Scores

ZYME

30score
Recommendation
EXTENDED

NTLA

33score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric ZYME NTLA Winner
Forward P/E 87.7193 0 Tie
PEG Ratio 0 -0.0969 Tie
Revenue Growth -90.6% -46.2% NTLA
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 30.0/100 32.9/100 NTLA
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED EXTENDED Tie

Relative Price Performance (Last 90 Days)

ZYME 1M: +24.0% · 3M: +14.2% NTLA 1M: +15.7% · 3M: +3.8%

Current Technical Phase

ZYME

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 72

RSI (14): 71.6 · Price: $28.67

NTLA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 55.1 · Price: $12.84

Fundamentals Snapshot

Metric ZYME NTLA
Market Cap
Forward P/E 24.4 -4.9
Trailing P/E
Revenue (TTM)
Revenue Growth -0.9% -0.5%
Gross Margin -2.5% -3.7%
Operating Margin -9.2% -14.7%
EPS -2.02 -3.34
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, NTLA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.